Of the N=24 EMDR Europe Consultants who took part in the study, all completed the VB2T treatment session and post-treatment, 1-mth, and 6-mth follow-up measures. There were no dropouts from the study. Tables 3 and 4 highlight the descriptive data regarding various measures – SUD, VOC, MV, ME, and MI, and pre, post, 1-mth, and 6-mth follow-up.
Hypothesis 1
Figure 1 shows the decrease in SUD and the increase in the Validity of Cognition (VOC) at the post, 1- and 6-month follow-up.
Additionally, in more detail, Table 5 highlights the mean, standard deviation, skewness, kurtosis, baseline, and p values for the SUD and VOC at pre, post, 1-mth and 6-mth follow-up and the maintenance of the VB2T treatment effect.
Table 5
Means, SD, skewness, and kurtosis for SUD and VOC at pre, post, 1-mth & 6-mth FU
| Mean (SD) | Skewness (SE) | Kurtosis (SE) | B (SE) | p value |
Pre-SUD | 7.75 (1.39) | -.15 (.47) | -.95 (.92) | 0 | |
Post-SUD | .21 (.49) | 2.72 (.47) | 7.73 (.92) | -1.02 (.03) | <.001* |
1 m FU SUD | .64 (.79) | .78 (.49) | -.89 (.95) | -.94 (.05) | <.001* |
6m FU SUD | .23 (.95) | -1.74 (.51) | 6.99 (.99) | -.99 (.01) | <.001* |
Pre-VOC | 2.02 (.79) | -.08 (.47) | -1.36 (.92) | 0 | |
Post-VOC | 6.96 (.20) | -4.90 (.47) | 24.00 (.92) | 1.22 (.07) | <.001* |
1 m FU VOC | 6.87 (.31) | -2.60 (.49) | 5.63 (.95) | 1.21 (.08) | <.001* |
6 m FU VOC | 6.92 (.25) | -3.34 (.52) | 11.19 (1.01) | 1.22 (.08) | <.001* |
There was a substantial reduction in SUD after receiving EMDR in comparison with the baseline assessment (B=-1.02, SE = .03, p < 0.001). The decrease in SUD maintained in the follow up assessments – 1month (B=-.94, SE = .05, p < 0.001) and 6 months (B=-.99, SE = .04, p < 0.001) in comparison with the baseline. Simultaneously, there was an increase in VOC after receiving EMDR in comparison with the baseline assessment (B=1.22, SE = .07, p < 0.001). The increase maintained after 1-month (B=1.21, SE = .08, p < 0.001) and 6 months (B=1.22, SE = .08, p < 0.001) post intervention.
The results of this study indicate that VB2T decreased the SUD and increase the VOC in the treatment of a pathogenic memory tested at pre, post, 1-mth and 6-mth follow-up, suggesting that using VB2T as a video conferencing psychotherapy demonstrated a treatment effect on the pathogenic memory when measured by the SUD and VOC. Furthermore, there was a statistically significant difference between pre-treatment (M = 7.75, SD = 1.39) and 6-month follow-up (M = 0.35, SD = 0.59), with a Hedges’ g effect size value (g = 6.71) suggesting high practical significance. Therefore, we reject the null hypothesis that there is no difference on the Subjective Unit of Disturbance (SUD) or Validity of Cognition (VOC) when using the VB2T EMDR intervention as a video-conference psychotherapy.
Hypothesis 2
Figure 2 shows the reduction in the nature and characteristics of the pathogenic memory, including memory vividness, emotionality, and intensity. For some research participants, alterations in memory characteristics indicated positive change rather than disturbance (negative), and therefore positive change is presented as a minus score.
As figure 2 demonstrates the VB2T intervention clearly impacted on three areas of distinctiveness of the pathogenic – memory vividness, emotionality, and intensity, with results maintained at both 1-mth and 6-mth FU. There were significant decreases in MV (B=-.42, SE = .05, p < 0.001), ME (B=-.61, SE = .03, p < 0.001), and MI (B=-.77, SE = .04, p < 0.001) following the intervention. These effects maintained in the first month follow-up for ME (B=-.65, SE = .06, p < 0.001), MI (B=-.79, SE = .03, p < 0.001), MV (B=-.60, SE = .07, p < 0.001), and sustained after six months for MV (B=-.58, SE = .03, p < 0.001), ME (B=-.62, SE = .03, p < 0.001), MI (B=-.79, SE = .04, p < 0.001). Overall, these results indicate changes that were consistently, statistically significant at p < 0.001. Additionally, results demonstrate a favourable dose effect, with potential evidence in support of resilience and post-traumatic growth, as indicated the treatment effect emphasises between pre and 6-mth FU. This represents a significant finding from this study.
Therefore, it would be reasonable to assume that when VB2T delivered as a VCP, it has the potential to instigate distinct changes to core components of the pathogenic memory, suggesting evidence of memory reconsolidation. Regarding hypothesis 2: Distinctiveness – VB2T, as a VCP, will have no impact in reducing Memory Intensity (MI), Memory Emotionality (ME), and Memory Vividness (MV) of a pathogenic memory following intervention when measured at post-treatment, 1-mth and 6-mth in comparison with a pre-measure, results do not support this, therefore we reject the null hypothesis
Hypothesis 3
Figures 3 & 4 demonstrate exposure to Adverse Childhood Experiences (ACEs) or Benevolent Childhood Experiences (BCEs) did not influence the processing of the pathogenic memory or the intervention outcome following the utilisation of VB2T.
As explained previously, testing the relevance hypothesis compared the study participant group with the original primary studies (35–39, 42). A single factor ANOVA explored the between-group variances. This one-way analysis of variance is a technique used to compare two or more samples when utilising numerical or categorical data.
Figure 4 highlights the prevalence of ACEs between studies (35, 42). A descriptive review of the results suggests higher exposure to 4+ ACEs within the VB2T participant group; however, results yielded a F(3, 4) = 8.45, p-value <.03* suggesting that there were indeed differences between the three groups in terms of the prevalence of ACEs, therefore rejecting the null hypothesis.
Table 6
Types of Adverse Childhood Experiences (ACE) * P<.001
ACEs | Incidence | Sig. (2-test) |
Psychological abuse | 7 (33%) | .189 |
Physical abuse | 2 (10%) | <.001* |
Sexual abuse | 4 (19%) | .007 |
Emotional neglect | 9 (43%) | .664 |
Physical neglect | 2 (9%) | <.001* |
Parental divorce | 6 (26%) | .035 |
Mother physical abuse | 0 (0%) | <.001* |
Household substance abuse | 4 (17%) | .003 |
Household mental illness | 8 (35%) | .210 |
Criminal behaviour in household | 0 (0%) | <.001* |
Table 6 provides more descriptive data of the VB2T participant group relating to specific exposure to adverse childhood experiences (ACEs). Results focussed on exposure to physical abuse, physical neglect, mother physical abuse, and criminal behaviour in the household.
Although an ANOVA revealed a distinction between the three groups, it is essential to highlight the elevated incidence of exposure to psychological abuse, emotional neglect, household mental illness, absence of exposure to mother physical abuse, and criminal behaviour in the household VB2T research participant group. Figure 5 rank scores the ten questions of the original ACEs questionnaire from most prevalent (1) to least (10).
Figure 6 compares the frequency of both ACEs and BCEs from the VB2T research population. The mean ACE of 1.8 (SD 1.68) and BCE of 7.6 (SD 2.06). The correlation between ACEs & BCEs is r(22) = -.48.
For the benevolent childhood experiences (BCEs), the mean for the sample was 7.6 (SD = 2.06), and the median was 8. As can be seen from Table 7, most participants reported having eight (17.4%), nine (21.7%), and ten (21.7%) benevolent experiences in their childhood. All participants reported at least four BCEs. Table 5 displays the frequency of each type of BCEs in the current sample. Results suggest that having "At least one good friend" (96%) and "Opportunities to have a good time" (91%) were the most frequent benevolent experiences.
Table 7
Types of Benevolent Childhood Experiences (BCEs)
BCEs | Incidence | Sig. (2-test) |
At least one caregiver with whom you felt safe | 18 (78%) | .011 |
At least one good friend | 22 (96%) | <.001* |
Beliefs that gave you comfort | 16 (70%) | .093 |
Enjoyment at school | 18 (78%) | .011 |
At least one teacher that cared | 20 (87%) | <.001* |
Good neighbours | 17 (74%) | .035 |
An adult (not a parent/ caregiver or the person from *11) who could provide you with support or advice | 12 (52%) | 1.000 |
Opportunities to have a good time | 21 (91%) | <.001* |
Like yourself or feel comfortable with yourself | 12 (52%) | 1.000 |
Predictable home routine, like regular meals and a regular bedtime | 20 (87%) | <.001* |
In exploring further hypothesis 3: Relevance – firstly, results seem to indicate that neither ACEs nor BCEs score bore no influence on the outcome. did not influence the outcome of the intervention. Secondly, although 75% of the research participants admitted their motivation for participation being based firmly on 'non-disclosure', however, results indicated 87.5% did disclose their target memory to the treating clinician. Of these 87.5%, Table 8 highlights the categories of target memories disclosed.
Table 8
Disclosed target memory themes and frequencies chosen by research participants for VB2T as a VCP
o sexual assault (3) o child abuse (4) o parental neglect (1) o fatal road traffic collision (1) o occupational bullying (4) o complicated grief (2) o episodes involving shame and humiliation (6) |
As indicated earlier, using VB2T demonstrates a distinct treatment effect with Table 8 highlighting clinical applicability. In addition, the desensitisation and reprocessing of these trauma memories occurred irrespective of either ACEs or BCEs. These results were consistent at 1 and 6-month FU. Consequently, this data set supports the assertion of hypothesis 3.
Regarding hypothesis 3 results suggest rejection of the null in relation to ACEs and BCEs.
In testing hypothesis 4: Efficiency – the administration of VB2T was tested against the period recommended by EMDRIA sessions; 60 – 90 minutes. Results for this study used a time metric (minutes) from commencement of Phase 3 – Assessment, to completion of Phase 7 – Closure (including debrief). Of the N=24 research participants, the average VB2T session was 57 minutes and 27 seconds, with an SD of 17 minutes 27 seconds. Results highlight that the treatment sessions were below the 60 Minutes threshold.
Testing the costing element within hypothesis 4 required economic modelling using University of Worcester financial algorithms. The UW costing model used for each VB2T treatment session was calculated at £56.49 (€66.36). Of the 24 clinical sessions of VB2T carried out the mean cost per session was £54.02 (€63.45). This represented potential modest savings of £2.47 (€2.91) per session. However, Figure 7 indicates the variance in treatment costs of each individual session. An additional consideration one of the distinct advantages of remote intervention is the reduction in client related costs, such as travel time, transportation, parking, etc.
Results indicate savings in terms of time and efficiency, with additional health economic benefits. Regarding hypothesis 4 results suggest rejection of the null.